AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

8,277.00p
   
  • Change Today:
      11.00p
  • 52 Week High: 8,812.00
  • 52 Week Low: 6,794.00
  • Currency: UK Pounds
  • Shares Issued: 1,549.12m
  • Volume: 2,399,016
  • Market Cap: £128,220m
  • RiskGrade: 123

Regulatory News

AZN: H1 2021 Results 29-Jul-2021 07:00 RNS
Ultomiris recommended in EU for children with PNH 26-Jul-2021 07:00 RNS
Directorate Change 22-Jul-2021 07:00 RNS
Director/PDMR Shareholding 21-Jul-2021 15:56 RNS
Total Voting Rights 21-Jul-2021 15:45 RNS
Acquisition of Alexion completed 21-Jul-2021 13:45 RNS
Imfinzi approved in China for extensive-stage SCLC 19-Jul-2021 07:00 RNS
Status on US FDA Advisory Committee for roxadustat 16-Jul-2021 07:00 RNS
AstraZeneca 15-Jul-2021 17:30 RNS
AstraZeneca-Alexion transaction cleared in the UK 14-Jul-2021 07:08 RNS
Tezepelumab granted FDA Priority Review for asthma 08-Jul-2021 07:00 RNS
AstraZeneca-Alexion transaction cleared in the EU 06-Jul-2021 07:00 RNS
Total Voting Rights 01-Jul-2021 15:00 RNS
Forxiga recommended in EU for patients with CKD 28-Jun-2021 07:05 RNS
Nirsevimab PhII/III trial confirms safety profile 28-Jun-2021 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 8,277.00p
Change Today 11.00p
% Change 0.13 %
52 Week High 8,812.00
52 Week Low 6,794.00
Volume 2,399,016
Shares Issued 1,549.12m
Market Cap £128,220m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
84.42% below the market average84.42% below the market average84.42% below the market average84.42% below the market average84.42% below the market average
1.96% below the sector average1.96% below the sector average1.96% below the sector average1.96% below the sector average1.96% below the sector average
Price Trend
14.9% below the market average14.9% below the market average14.9% below the market average14.9% below the market average14.9% below the market average
4.92% above the sector average4.92% above the sector average4.92% above the sector average4.92% above the sector average4.92% above the sector average
Income
31.42% below the market average31.42% below the market average31.42% below the market average31.42% below the market average31.42% below the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Growth
88.35% above the market average88.35% above the market average88.35% above the market average88.35% above the market average88.35% above the market average
82.86% above the sector average82.86% above the sector average82.86% above the sector average82.86% above the sector average82.86% above the sector average

What The Brokers Say

Strong Buy 21
Buy 2
Neutral 3
Sell 0
Strong Sell 1
Total 27
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 12-Aug-21 25-Feb-21
Paid 13-Sep-21 29-Mar-21
Amount 90.00¢ 190.00¢

Trades for 29-Jul-2021

Time Volume / Share Price
16:36 21 @ 8,277.00p
16:36 1,000 @ 8,277.00p
16:36 300 @ 8,277.00p
16:36 100 @ 8,277.00p
16:35 918,420 @ 8,277.00p

Top of Page